Rapid Progression of Advanced “Hormone-Resistant” Prostate Cancer During Palliative Treatment with Progestins for Cancer Cachexia Davide Tassinari, MD, Francesca Fochessati, MD, Ilaria Panzini, PhD, Barbara Poggi, MD, Sergio Sartori, MD, Alberto Ravaioli, MD Journal of Pain and Symptom Management Volume 25, Issue 5, Pages 481-484 (May 2003) DOI: 10.1016/S0885-3924(03)00043-5
Fig. 1 PSA levels during and after the discontinuation of treatment with megestrol acetate (Patient #1). Journal of Pain and Symptom Management 2003 25, 481-484DOI: (10.1016/S0885-3924(03)00043-5)
Fig. 2 PSA levels during and after the discontinuation of treatment with megestrol acetate (Patient #2). Journal of Pain and Symptom Management 2003 25, 481-484DOI: (10.1016/S0885-3924(03)00043-5)
Fig. 3 PSA levels during and after the discontinuation of treatment with megestrol acetate (Patient #3). Journal of Pain and Symptom Management 2003 25, 481-484DOI: (10.1016/S0885-3924(03)00043-5)